Literature DB >> 15448524

Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation.

Kristin Engelhard1, Christian Werner, Eva Eberspächer, Monika Pape, Uta Stegemann, Kristine Kellermann, Regina Hollweck, Peter Hutzler, Eberhard Kochs.   

Abstract

BACKGROUND: Propofol reduces neuronal damage from cerebral ischemia when investigated for less than 8 postischemic days. This study investigates the long-term effects of propofol on neuronal damage and apoptosis-related proteins after cerebral ischemia and reperfusion.
METHODS: Male Sprague-Dawley rats were randomly assigned as follows: group 1 (n = 32, control): fentanyl and nitrous oxide-oxygen; group 2 (n = 32, propofol): propofol and oxygen-air. Ischemia (45 min) was induced by carotid artery occlusion and hemorrhagic hypotension. Pericranial temperature and arterial blood gases were maintained constant. After 1, 3, 7, and 28 postischemic days, brains were removed, frozen, and sliced. Hippocampal eosinophilic cells were counted. The amount of apoptosis-related proteins Bax, p53, Bcl-2, and Mdm-2 and neurons positive for activated caspase-3 were analyzed.
RESULTS: In propofol-anesthetized rats, no eosinophilic neurons were detected, whereas in control animals, 16-54% of hippocampal neurons were eosinophilic (days 1-28). In control animals, the concentration of Bax was 70-200% higher after cerebral ischemia compared with that in animals receiving propofol over time. Bcl-2 was 50% lower in control animals compared with propofol-anesthetized rats during the first 3 days. In both groups, a maximal 3% of the hippocampal neurons were positive for activated caspase-3.
CONCLUSIONS: These data show sustained neuroprotection with propofol. This relates to reduced eosinophilic and apoptotic injury. Activated caspase-3-dependent apoptotic pathways were not affected by propofol. This suggests the presence of activated caspase-3-independent apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448524     DOI: 10.1097/00000542-200410000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  19 in total

1.  Propofol exerts hippocampal neuron protective effects via up-regulation of metallothionein-3.

Authors:  Jianguo He; Changshun Huang; Juan Jiang; Lanhai Lv
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

Review 2.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

Review 3.  Considerations for the use of anesthetics in neurotoxicity studies.

Authors:  Sumedha W Karmarkar; Kathleen M Bottum; Shelley A Tischkau
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

4.  Direct assessment of the antioxidant properties of midazolam by electron spin resonance spectroscopy.

Authors:  Mitsuuru Hata; Kyo Kobayashi; Fumihiko Yoshino; Ayaka Yoshida; Shuta Sugiyama; Chihiro Miyamoto; Fumiaki Tokutomi; Yojiro Maehata; Satoko Wada-Takahashi; Shun-Suke Takahashi; Tomoko Komatsu; Kazu-Ichi Yoshida; Masaichi-Chang-Il Lee
Journal:  J Anesth       Date:  2011-06-18       Impact factor: 2.078

5.  3,4-oxo-isopropylidene-shikimic acid inhibits cerebral ischemia-induced oxidative stress and neuronal apoptosis in rats.

Authors:  Ling-Ling Tang; Jing-Ya Ye; Sheng-Nan Jiang; Jie-Sheng Zheng
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 6.  The role of Wnt/mTOR signaling in spinal cord injury.

Authors:  Peng Cheng; Hai-Yang Liao; Hai-Hong Zhang
Journal:  J Clin Orthop Trauma       Date:  2022-01-04

7.  Cerebral microembolization during primary total hip arthroplasty and neuropsychologic outcome: a pilot study.

Authors:  Rahul V Patel; Jan Stygall; Jane Harrington; Stanton P Newman; Fares S Haddad
Journal:  Clin Orthop Relat Res       Date:  2009-10-17       Impact factor: 4.176

8.  Resveratrol improves neuron protection and functional recovery through enhancement of autophagy after spinal cord injury in mice.

Authors:  Jinquan Hu; Hui Han; Peng Cao; Wenchao Yu; Chen Yang; Yang Gao; Wen Yuan
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 9.  Propofol for sedation in neuro-intensive care.

Authors:  Michael P Hutchens; Stavros Memtsoudis; Nicholas Sadovnikoff
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 10.  The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties.

Authors:  Yoshinori Kotani; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.